Mineralys Therapeutics, Inc. Common Stock Working Capital to Net Assets Ratio
Mineralys Therapeutics, Inc. Common Stock working capital to net assets ratio. Mineralys Therapeutics, Inc. Common Stock (MLYS) has a Working Capital to Net Assets ratio of 117.3% as of June 2026. Working capital of $646.48 Million (current assets of $665.80 Million minus current liabilities of $19.32 Million) is measured against net assets of $550.92 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check MLYS intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Mineralys Therapeutics, Inc. Common Stock (2020–2025)
Working capital to net assets ratio of Mineralys Therapeutics, Inc. Common Stock from 2020 to 2025. This chart shows how Mineralys Therapeutics, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 117.3%, reflecting working capital of $646.48 Million against net assets of $550.92 Million USD. See Mineralys Therapeutics, Inc. Common Stoc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Mineralys Therapeutics, Inc. Common Stock Working Capital to Net Assets Ratio by Year (2020–2025)
Mineralys Therapeutics, Inc. Common Stock working capital to net assets ratio by year from 2020 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Mineralys Therapeutics, Inc. Common Stock from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Mineralys Therapeutics, Inc. Common Stoc asset portfolio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.9% | $646.27 Million | $646.69 Million | $661.39 Million | $15.11 Million | ▲ +0.2 pp |
| 2024 | 99.7% | $190.71 Million | $191.26 Million | $205.35 Million | $14.65 Million | ▲ +0.8 pp |
| 2023 | 98.9% | $238.62 Million | $241.15 Million | $249.10 Million | $10.48 Million | ▲ +299.3 pp |
| 2022 | -200.4% | $104.74 Million | $-52.27 Million | $112.81 Million | $8.07 Million | ▼ -173.9 pp |
| 2021 | -26.5% | $6.07 Million | $-22.93 Million | $11.12 Million | $5.05 Million | ▼ -127.0 pp |
| 2020 | 100.6% | $-3.62 Million | $-3.60 Million | $1.47 Million | $5.08 Million | — |